Page last updated: 2024-08-18

isomethyleugenol and Hodgkin Disease

isomethyleugenol has been researched along with Hodgkin Disease in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's4 (50.00)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Ahuja, A; Ambinder, RF; Barzilai, E; Dann, EJ; Eran, Y; Horowitz, NA; Hsieh, WS; Journo, G; Kanakry, JA; Low, JSW; Shamay, M; Stone, J; Woo, WL; Xian, RR1
Avrahami, C; Casanova, I; Cid, J; Climent, F; Davalos, V; Domingo-Domènech, E; Encuentra, M; Espejo-Herrera, N; Esteller, M; Esteve-Puig, R; Farré, L; Fernández, AF; Fraga, MF; Kol, N; Lopez, M; Mangues, R; Moshitch-Moshkovitz, S; Navarro, JT; Ortiz-Barahona, V; Piñeyro, D; Piris, MA; Rea, A; Rechavi, G; Santamarina-Ojeda, P; Soler, M; Sureda, A; Tapia, G; Villanueva, A1
Fujimoto, H; Imamura, M; Kato, N; Kondo, T; Matsumura, N; Minami, Y; Oishi, I; Tanaka, Y; Tsukada, J; Yoda, A1
Ambinder, RF; Gulley, ML; Manns, A; Robertson, KD; Swinnen, LJ; Zong, JC1
Ambinder, RF; Moore, SM; Robertson, KD; Yang, J1
Ambinder, RF; Robertson, KD; Srivastava, G; Swinnen, LJ; Tao, Q; Yang, J1
Achten, S; Behn-Krappa, A; Diehl, V; Doerfler, W; Hölker, I; Jücker, M; Schmitz, B; Sprengel, J; Tesch, H1
Baugh, CM; Butterworth, CE; Krumdieck, C1

Reviews

1 review(s) available for isomethyleugenol and Hodgkin Disease

ArticleYear
Epstein-Barr virus as a therapeutic target in Hodgkin's disease and nasopharyngeal carcinoma.
    Seminars in cancer biology, 1996, Volume: 7, Issue:4

    Topics: Antigens, Viral; Carrier State; CD8-Positive T-Lymphocytes; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Viral; Herpesviridae Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunotherapy; Methylation; Nasopharyngeal Neoplasms; T-Lymphocytes; Thymidine Kinase; Tumor Virus Infections; Viral Matrix Proteins

1996

Other Studies

7 other study(ies) available for isomethyleugenol and Hodgkin Disease

ArticleYear
CpG methylation in cell-free Epstein-Barr virus DNA in patients with EBV-Hodgkin lymphoma.
    Blood advances, 2020, 04-28, Volume: 4, Issue:8

    Topics: DNA, Viral; Epstein-Barr Virus Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Methylation

2020
Epigenetic loss of m1A RNA demethylase ALKBH3 in Hodgkin lymphoma targets collagen, conferring poor clinical outcome.
    Blood, 2021, 02-18, Volume: 137, Issue:7

    Topics: AlkB Homolog 3, Alpha-Ketoglutarate-Dependent Dioxygenase; Base Sequence; Cell Line, Tumor; Collagen Type I; Collagen Type I, alpha 1 Chain; CpG Islands; Datasets as Topic; Decitabine; DNA Methylation; DNA, Neoplasm; Hodgkin Disease; Humans; Leukocytes, Mononuclear; Lymphocytes; Methylation; Neoplasm Proteins; Promoter Regions, Genetic; RNA Interference; RNA Processing, Post-Transcriptional; RNA, Neoplasm; Sequence Alignment; tRNA Methyltransferases

2021
Regulation of Chk2 gene expression in lymphoid malignancies: involvement of epigenetic mechanisms in Hodgkin's lymphoma cell lines.
    Cell death and differentiation, 2004, Volume: 11 Suppl 2

    Topics: Acetylation; Apoptosis; Azacitidine; Butyrates; Cell Line, Tumor; Checkpoint Kinase 2; Decitabine; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histones; Hodgkin Disease; Humans; Hydroxamic Acids; Lymphoma; Methylation; Protein Serine-Threonine Kinases; RNA, Messenger

2004
CpG methylation of the major Epstein-Barr virus latency promoter in Burkitt's lymphoma and Hodgkin's disease.
    Blood, 1996, Oct-15, Volume: 88, Issue:8

    Topics: 5-Methylcytosine; Anemia, Aplastic; Burkitt Lymphoma; CpG Islands; Cytosine; DNA (Cytosine-5-)-Methyltransferases; DNA-Binding Proteins; DNA, Neoplasm; DNA, Viral; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; Ghana; Herpesviridae Infections; Herpesvirus 4, Human; Hodgkin Disease; Immunocompromised Host; Immunodominant Epitopes; Immunologic Surveillance; Lymphoma, B-Cell; Methylation; Neoplasm Proteins; Promoter Regions, Genetic; Tumor Virus Infections; Virus Latency

1996
Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis.
    The American journal of pathology, 1999, Volume: 155, Issue:2

    Topics: Burkitt Lymphoma; Carcinoma; Cell Line; Herpesvirus 4, Human; Hodgkin Disease; Humans; Immunosuppression Therapy; Lymphoma; Lymphoma, B-Cell; Methylation; Models, Genetic; Nasopharyngeal Neoplasms; Polymerase Chain Reaction; Promoter Regions, Genetic; Tumor Cells, Cultured

1999
Patterns of DNA methylation in selected human genes in different Hodgkin's lymphoma and leukemia cell lines and in normal human lymphocytes.
    Cancer research, 1991, Jul-15, Volume: 51, Issue:14

    Topics: Base Sequence; DNA; Genes, myc; Genes, ras; Genome, Human; Hodgkin Disease; Humans; Leukemia; Lymphocytes; Lymphotoxin-alpha; Methylation; Proto-Oncogenes; Tumor Cells, Cultured

1991
A study of folate absorption and metabolism in man utilizing carbon-14--labeled polyglutamates synthesized by the solid phase method.
    The Journal of clinical investigation, 1969, Volume: 48, Issue:6

    Topics: Adult; Aged; Biological Assay; Carbon Isotopes; Chemical Phenomena; Chemistry; Enterococcus faecalis; Feces; Female; Folic Acid; Glutamates; Hodgkin Disease; Humans; Intestinal Absorption; Lactobacillus; Leukemia, Lymphoid; Male; Methods; Methylation; Middle Aged

1969